The long-term goal of our Targeted Therapeutics research program is to help people with a lung cancer diagnosis live longer and healthier lives. LUNGevity awardees are at the forefront of precision medicine — bringing the right therapy, in the right dose, to the right patient, at the right time — by answering these important questions:
- How can we match the right patient to the right therapies for maximum effectiveness and minimum side effects?
- How do we overcome resistance to therapies so that patients can benefit from them longer?
- How do we best sequence/combine therapies for maximum effect?
- How do we build on the early successes of immunotherapy?
Projects funded to date fall under the following categories.